ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
22.91
+0.10 (0.44%)
Jun 27, 2025, 4:00 PM - Market closed

ArriVent BioPharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
784898---
Enterprise Value
608615---
Last Close Price
24.8926.64---
PB Ratio
4.183.48---
P/TBV Ratio
3.873.48---
Debt / Equity Ratio
0.000.000.000.00-
Quick Ratio
13.6312.7013.0019.6020.64
Current Ratio
14.3413.1413.7621.8523.63
Return on Equity (ROE)
-49.00%-39.36%-42.57%-34.22%-
Return on Assets (ROA)
-23.10%-26.91%-26.95%-20.42%-
Return on Capital (ROIC)
-24.10%-28.79%-28.58%-21.38%-
Earnings Yield
-16.26%-8.97%---
Buyback Yield / Dilution
-316.83%-1369.88%-67.64%-79.57%-
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q